Blade Therapeutics, Inc. — Form D

Blade Therapeutics, Inc. of South San Francisco, CA, a company, filed a Form D exempt-offering notice with the SEC on 2019-10-24. The offering totals $50.0M, of which $38.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (22)

NameRoleLocation
Peter V Van VlasselaerDirectorSouth San Francisco, CA
Cameron V WheelerDirectorSouth San Francisco, CA
Elaine JonesDirectorSOUTH SAN FRANCISCO, CA
Luke EvninDirectorWatertown, MA
Cameron WheelerDirectorCambridge, MA
Peter Van VlasselaerDirectorNew York, NY
William SlatteryDirectorBala Cynwyd, PA
Prabha Shirley IbrahimExecutive OfficerSouth San Francisco, CA
William V SlatteryDirectorSouth San Francisco, CA
James B ScopaDirectorSouth San Francisco, CA
Gary B PatouExecutive OfficerSouth San Francisco, CA
Lloyd B KlicksteinDirectorSouth San Francisco, CA
Cameron Shirley WheelerDirectorSouth San Francisco, CA
Peter Shirley Van VlasselaerDirectorSouth San Francisco, CA
Luke Shirley EvninDirectorSouth San Francisco, CA
Wendye Rae RobbinsDirectorSouth San Francisco, CA
Wendye Rae RobbinsExecutive OfficerSouth San Francisco, CA
Rana Rae Al-HallaqDirectorSouth San Francisco, CA
M. Shirley ChiangExecutive OfficerSouth San Francisco, CA
James ScopaDirectorSan Diego, CA
Wendye RobbinsDirectorSOUTH SAN FRANCISCO, CA
Wendye RobbinsExecutive OfficerSOUTH SAN FRANCISCO, CA

Other filings by this issuer (2)

FiledFormOfferingSold
2019-10-24D$24.0M$12.0M
2016-06-20D$45.4M$27.1M

More